Dr. Ilson Discusses the Findings of the RTOG 0436 Trial
У вашего броузера проблема в совместимости с HTML5
David H. Ilson, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the conclusions of the RTOG 0436 trial, a phase III trial of cisplatin, paclitaxel and radiation with or without cetuximab in the non-operative treatment of esophageal cancer